Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2004.02083.xPMID 15298643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

  2003cited by this paper
• Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus.

  2002cited by this paper
• Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

  2002cited by this paper
• A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.

  2001cited by this paper
• Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis

  2000cited by this paper
• In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.

  2000cited by this paper
• Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

  2000cited by this paper
• Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors

  2000cited by this paper
• Introduction to antifungal drugs.

  2000cited by this paper
• New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.

  2000cited by this paper
• In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

  2000cited by this paper
• New targets and delivery systems for antifungal therapy.

  2000cited by this paper
• In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.

  2000cited by this paper
• Diagnosis and Treatment of Oropharyngeal Candidiasis in Patients Infected with HIV: A Critical Reassessment

  1999cited by this paper
• Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.

  1998cited by this paper
• Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

  1998cited by this paper
• Identification of immune-related protein kinases from mosquitoes (Aedes aegypti).

  1998cited by this paper
• Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.

  1997cited by this paper
• A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.

  1997cited by this paper
• Current therapy of infectious disease

  1996cited by this paper
• Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort

  1996cited by this paper
• Antifungal agents: chemotherapeutic targets and immunologic strategies

  1996cited by this paper
• Resistant Candidiasis

  1994cited by this paper
• Textbook of AIDS Medicine

  1994cited by this paper
• The prevalence of oral lesions in HIV‐infected homosexual and bisexual men: three San Francisco epidemiological cohorts

  1991cited by this paper
• Infection in Cancer Patients

  1989cited by this paper
• Acquired immunodeficiency syndrome in a heterosexual population in Zaire.

  1984cited by this paper
• Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti.

  1983cited by this paper
• Surgery in hypertension.

  1948cited by this paper

• ABORDAGEM TERAPÊUTICA PARA PACIENTES COM CANDIDÍASE ESOFÁGICA: UMA REVISÃO DE LITERATURA

  2024cites this paper
• Echinocandins in antifungal pharmacotherapy

  2017cites this paper
• Mechanism of Antifungal Triazoles and Related Drugs: Electron Transfer, Reactive Oxygen Species and Oxidative Stress

  2017cites this paper
• Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient

  2016cites this paper
• Detection of Aflatoxin in Aspergillus Species Isolated from Immunocompromised Hospitalized Patients

  2016cites this paper
• Clinical hepatotoxicity associated with antifungal agents

  2016cites this paper
• Lipopeptides: Status and Strategies to Control Fungal Infection

  2016cites this paper
• Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.

  2015cites this paper
• Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study

  2015cites this paper
• Micafungin: an evidence-based review of its place in therapy

  2014cites this paper
• Recent advances in the treatment of life-threatening, invasive fungal infections

  2013cites this paper
• Invasive candidiasis: update on current pharmacotherapy options and future perspectives

  2013cites this paper
• Efficacy and Safety of Micafungin for Febrile Neutropenia in Pediatric Patients With Hematological Malignancies: A Multicenter Prospective Study

  2013cites this paper
• RECENT DEVELOPMENTS IN ANTIFUNGAL AGENTS

  2012cites this paper
• RECENT DEVELOPMENTS IN ANTIFUNGAL AGENTS Review Article

  2012cites this paper
• Micafungin for candidiasis

  2012cites this paper
• Micafungin

  2012cites this paper
• Micafungin Review of its Use in the Prophylaxis and Treatment of

  2012cites this paper
• Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis

  2011cites this paper
• [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].

  2011cites this paper
• Natural Products in Drug Discovery: Impacts and Opportunities — An Assessment

  2011cites this paper
• Overview of treatment options for invasive fungal infections.

  2011cites this paper
• Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report

  2011cites this paper
• effi cacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis : a prospective observational study

  2011cites this paper
• New β-glucan inhibitors as antifungal drugs

  2011cites this paper
• Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

  2011cites this paper
• Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study.

  2011cites this paper
• Echinocandin pharmacodynamics: review and clinical implications.

  2010cites this paper
• Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

  2010cites this paper
• Antifungals to treat Candida albicans

  2010cites this paper
• [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].

  2009cites this paper
• Review of the pharmacology and clinical studies of micafungin

  2009cites this paper
• Micafungin - the newest echinocandin.

  2009cites this paper
• Micafungin: a sulfated echinocandin

  2009cites this paper
• Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice*

  2009cites this paper
• Pharmacotherapy of Micafungin: Clinical Review

  2009cites this paper
• Servicio de Lactantes y Niños Pequeños, Hospital Universitario 12 de Octubre, Madrid, España

  2009cites this paper
• Utilidad clínica de la micafungina en el tratamiento de las candidiasis invasoras en el paciente oncohematológico

  2009cites this paper
• Echinocandins: The Newest Class of Antifungals

  2009cites this paper
• Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center

  2008cites this paper
• Micafungin for the prophylaxis and treatment of Candida infections

  2008influential citation
• Echinocandins: a wealth of choice – how clinically different are they?

  2008cites this paper
• Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

  2008cites this paper
• Comparison of echinocandin antifungals

  2007cites this paper
• Recent advances in antifungal chemotherapy.

  2007cites this paper
• Efficacy and safety of micafungin in febrile neutropenic patients treated for hematological malignancies.

  2007cites this paper
• Relationship between the initial dose of micafungin and its efficacy in patients with candidemia

  2007cites this paper
• A comparative evaluation of properties and clinical efficacy of the echinocandins

  2007cites this paper
• Clinical pharmacology of antifungal agents in pediatric patients

  2007cites this paper
• The Echinocandins

  2007cites this paper
• Novel Antifungal Therapies

  2007cites this paper
• Invasive fungal infections in children: advances and perspectives

  2007cites this paper
• Echinocandins in the management of invasive fungal infections, part 1.

  2006cites this paper
• Echinocandin antifungals: review and update

  2006cites this paper
• Emerging echinocandins for treatment of invasive fungal infections

  2006cites this paper
• Gastrointestinal infections in immunocompromised hosts

  2006cites this paper
• The Echinocandins: Comparison of Their Pharmacokinetics, Pharmacodynamics and Clinical Applications

  2006cites this paper
• Developments in the treatment of candidiasis: more choices and new challenges

  2006cites this paper
• Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.

  2006cites this paper
• New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.

  2006cites this paper
• Micafungin: a new echinocandin.

  2006cites this paper
• A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.

  2006cites this paper
• Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

  2006cites this paper
• [In vitro susceptibilities to caspofungin and micafungin of clinical isolates of Candida species.].

  2006cites this paper
• Systemic antifungal agents: an update of established and new therapies.

  2006cites this paper
• New Antifungal Drugs and the Pediatric Cancer Patient: Current Status of Clinical Development

  2005cites this paper
• Micafungin Sodium

  2005influential citation
• A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis

  2005cites this paper
• International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

  2005cites this paper
• MICAFUNGIN ( MYCAMINE TM ) : A NEW ANTIFUNGAL AGENT

  2005cites this paper
• Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

  2005cites this paper
• Echinocandins: role in antifungal therapy, 2005

  2005cites this paper
• Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant

  2005cites this paper
• Micafungin: the US perspective

  2005cites this paper
• UPDATE ON STATINS IN ACS

  2005cites this paper
• Micafungin

  2004cites this paper
• A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.

  2004cites this paper